Effect of hyperthermia on invasion ability and TGF-β1 expression of breast carcinoma MCF-7 cells

Oncology Reports

Volumn 25, Issue 6, 2011, Pages 1573-1579

  Xie, Xiaoxue ^a,b   Shao, Xunfan ^a   Gao, Fuping ^b   Jin, Hekun ^b,c   Zhou, Jumei ^b,c   Du, Lehui ^b   Zhang, Yingying ^b   Ouyang, Weiwei ^b   Wang, Xiaowen ^b   Zhao, Lingyun ^b   Zhang, Xiaodong ^b   Tang, Jintian ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b TSINGHUA UNIVERSITY   (China)

^c HUNAN CANCER HOSPITAL   (China)

Author keywords

Cancer; Hyperthermia; Invasion; MCF 7 cells

Indexed keywords

EPIDERMAL GROWTH FACTOR; GELATINASE A; GELATINASE B; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CANCER INVASION; CARCINOMA CELL; CELL STRAIN MCF 7; DOWN REGULATION; ENZYME ACTIVITY; ENZYME RELEASE; HEATING; HYPERTHERMIC THERAPY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79954532496     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1240     Document Type: Article

References (28)

1. Nagashima K, Takagi R and Hoshina H: Effect of local hyperthermia on metastases in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 31: 84-89, 2002.
2. Sato T, Sawaji Y, Matsui N, Sato H, Motoharu S, Mori Y and Ito A: Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion. Biochem Biophys Res Commun 265; 139-193, 1999.
3. Sawaji Y, Sato T, Seiki M and Ito A: Heat shock-mediated transient increase in intracellular 3′,5′-cyclic AMP results in tumor specific suppression of membrane type 1-matrix metalloproteinase production and progelatinase A activation. Clin Exp Metastasis 18: 131-138, 2000. (Pubitemid 32165246)
4. Sawaji Y, Sato T, Takeuchi A, Hirata M and Ito A: Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro. Br J Cancer 86: 1597-1603, 2002. (Pubitemid 34628114)
5. Wikstrom P, Stattin P, Franck-Lissbrant I, Damber JE and Bergh A: Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer. Prostate 37: 19-29, 1980.
6. Kang Y, Siegel PM, Shu WP, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA and Massague J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549, 2003. (Pubitemid 36808649)
7. Sanchez ET, Botella LM, Velasco B, Corbi A, Attisano L and Bernabeu C: Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem 276: 38527-38535, 2001.
8. Derynck R, Akhurst RJ and Balmain A: TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129, 2001. (Pubitemid 32952643)
9. Hagedorn HG, Bachmeier BE and Nerlich AG: Synthesis and degradation of basement membranes and extracellular matrix and their regulation by TGF-beta in invasive carcinomas. Int J Oncol 18: 669-681, 2001.
10. Shafie SM and Liotta LA: Formation of metastasis by human breast carcinoma cells (MCF-7) in nude mice. Cancer Lett 11: 81-87, 1980. (Pubitemid 11179857)
11. NCI, On-line at: http://seer.cancer.gov/statfacts/html/breast. Html 2008.
12. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
13. Chiang WC, Wong YK, Lin SC, Chang KW and Liu CJ: Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin-3-gallate suppress MMP-13 expression. Oral Diseases 12: 27-33, 2006.
14. Puente XS, Sanchez LM, Overall CM and Lopez-Otin C: Human and mouse proteases: a comparative genomic approach. Nat Rev Genet 4: 544-558, 2003. (Pubitemid 36781345)
15. Nelson AR, Fingleton B, Rothenberg ML and Matrisian LM: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18: 1135-1149, 2000. (Pubitemid 30123793)
16. Ispanovic E and Haas TL: JNK and PI3K differentially regulate MMP-2 and MT1-MMP mRNA and protein in response to actin cytoskeleton reorganization in endothelial cells. Am J Physiol Cell Physiol 291: 579-588, 2006.
17. Tammela T, Enholm B, Alitalo K and Paavonen K: The biology of vascular endothelial growth factors. Cardiovasc Res 65: 550-563, 2005. (Pubitemid 40138976)
18. Welm AL: TGF β primes breast tumor cells for metastasis. Cell 133: 27-28, 2008.
19. Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T and Okumura K: Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with non-small cell lung carcinoma. Cancer 91: 964-971, 2001.
20. Saito H, Tsujitani S, Oka S, Kondo A, Ikeguchi M, Maeta M and Kaibara N: The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer 86: 1455-1462, 1999. (Pubitemid 29489778)
21. Tsushima H, Kawata S, Tamura S, Ito N, Shirai Y, Kiso S, Imai Y, Shimomukai H, Nomura Y, Matsuda Y and Matsuzawa Y: High levels of transforming growth factor beta 1 in patients with colorectal cancer:association with disease progression. Gastroenterology 110: 375-382, 1996. (Pubitemid 26043869)
22. Bhowmick NA, Neilson EG and Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature 432: 332-337, 2004. (Pubitemid 39551661)
23. Kalluri R and Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 6: 392-401, 2006.
24. Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4: 71-78, 2004.
25. Oft M, Heider KH and Beug H: TGF-beta signaling is necessary for carcinoma invasiveness and metastasis. Curr Biol 8: 1243-1252, 1998. (Pubitemid 28540052)
26. Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, Massague J, Mundy GR and Guise TA: TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 103: 197-206, 1999. (Pubitemid 29053137)
27. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A and Akhurst RJ: TGF beta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86: 531-542, 1996. (Pubitemid 26299485)
28. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR and Massagué J: TGF beta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133: 66-77, 2008. (Pubitemid 351442989)